Daniel Catenacci
Five Prime trial investigator pleads guilty to $134K insider trading scheme, faces up to 25 years in prison
A trial investigator involved with a Phase II study run by the biotech Five Prime Therapeutics has pled guilty to an insider trading probe. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
